Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy.

Bracco International BV wholesales and distributes pharmaceutical products. It engages in the promotion and marketing of products manufactured by Bracco SpA across the world. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands.

Zambon Group SpA engages in the production of chemicals and medicines. The company was founded in 1906 and is headquartered in Bresso, Italy.

Part of Hovione Farmaci��ncia SA, Hovione Inter AG is a company headquartered in Lucerne, Switzerland, that trades pharmaceutical products.

DONGKOOK Pharm. Co. Ltd. constructed the prefilled syringe system in its second factory (located at Kwanghyewon-myeon, Jincheon-gun, Chungbuk) for the first time in Asia and produced a large amount of various kinds of ultramodern injection agents. Located on its site are its central research institute, raw material factory, etc. where the raw materials of its main products are extracted and synthesized directly. Also, its third factory completed in 1994 is equipped with ultramodern facilities and is by no means inferior to other factories as the base of a leading company in a new millennium. Particularly, DONGKOOK invests more than 5% of the annual sale for research and development expenses while operating its central research institute centered on holders of master’s degree and PhD.

Part of Kerry Group Plc, Fructamine SpA is a company headquartered in Italy that develops flavorings and extracts. On May 10, 2004 Kerry Group Plc acquired Fructamine SpA.

Hubei Tianshu Pharmaceutical Co., Ltd., established on 2016-04-15, The business scope includes pharmaceutical raw materials,Pharmaceutical Intermediates,Medicinal Chemical Products,Pharmaceutical and chemical intermediates,Development of small volume injections,production and sales(Does not contain medical devices,Flammable and explosive,Hazardous Chemicals);Goods and technology import and export business.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Chengdu Lijing Technology Co., Ltd., established on 2012-09-20, Business scope includes biomedical research and development;new luminescent material,Chemical Products(Free of Hazardous Chemicals)research and development,production and sales;medicine,Technical development of pharmaceutical and chemical intermediates and new materials,technical consulting,technology transfer;Goods and technology import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Zhejiang Haizhou Pharmaceutical Co., Ltd., established on 1997-08-11, Business scope includes raw materials(See the specific scope<Pharmaceutical Production License>,Operate with a valid license)manufacture,Organic intermediate(only refers to3-chlorine-1,2-Propylene Glycol,iodotrimethylsilane,Bromotrimethylsilane,tert-butyl bromoacetate,tert-butyl chloroacetate,Hexamethyldisilane,18%Ammonia,Annual by-products:Hexamethyldisiloxane,30%hydrochloric acid)manufacture,toluene,ethanol,ethyl acetate,Triethylamine,Dichloromethane,Cyclohexane,Methanol,Xylene,Acetic acid,Isopropanol Recovery(The above projects are operated with valid licenses);Sodium chloride recovery,Sales,Manufacturing of organic intermediates(Removal of hazardous chemicals and precursor chemicals),Chemical raw materials(Free of hazardous chemicals and precursor chemicals,firecrackers,medicine,civilian explosives)wholesale,retail,Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

iMax Diagnostic Imaging Holding Ltd. engages in the manufacturing of active pharmaceutical ingredients. The company was founded on July 20, 2007 and is headquartered in Hong Kong.

Zhejiang Puli Pharmaceutical Co., Ltd., established on 2003-08-13, Business scope includes licensed projects:Drug Wholesale;Drug retail;pharmaceutical production;Production of Class II Medical Devices;food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Pharmaceutical special equipment sales;Machinery sales;Metal Material Sales;food sales(Only sell prepackaged food);Chemical product sales(No licensed chemical products);Sales of electronic components and electromechanical components;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Anhui Puli Pharmaceutical Co., Ltd., established on 2018-09-10, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Veterinary drug production;Veterinary drug business;Inspection and testing service;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Hainan Poly Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The firm is specialized in injections and oral solid formulations. Its products include injection, oral solid dosage, dry suspension and active pharmaceutical ingredient (API). The company was founded by Min Hua Fan on July 14, 1992 and is headquartered in Haikou, China.

Dai Nippon Printing Co., Ltd. engages in the provision of publishing and commercial printing services. It operates through the following segments: Information Communication, Lifestyle and Industrial Supplies, Electronics, and Beverages. The Information Communication segment involves in the manufacture and sale of publications, commercial printing materials, business forms, and educational and publications distribution. The Lifestyle and Industrial Supplies segment offers packaging materials, interior and exterior construction materials, photographic materials, and industrial supplies. The Electronics segment handles precision electronic components and other products. The Beverages segment produces and sells carbonated and non-carbonated beverages. The company was founded on October 9, 1876 and is headquartered in Tokyo, Japan.

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of over 3,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey and in the United States of America. A field force of more than 1,700 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. Consolidated revenue for 2012 was € 828.3 million, operating income was € 167.0 million and net income was € 118.5 million.

Manufactures pharmaceutical products

Shanghai Mingjie Pharmaceutical Technology Co., Ltd., established on 2018-11-19, Business scope includes general items:in medical technology,Biotechnology,Technology development in the field of detection technology,technology transfer,Technical Services,technical consulting,Instrumentation,Development of electromechanical equipment,Sales,Conference and Exhibition Services,Specialty Chemicals(Free of Hazardous Chemicals),Experimental analysis instrument,Sales of hygiene products and single-use medical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Huaqing Runde Technology Co., Ltd., established on 2004-05-26, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Import and export,Technology Import and Export,Agent import and export;Sales of machinery and equipment,building materials,Security Technology Protection Products,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals).(After receiving this license,It should be filed with the District and County Commerce Commission.;Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Jiangxi Brothers Pharmaceutical Co., Ltd., established on 2014-08-12, Business scope includes licensed projects:Feed additive production,Food additive production,pharmaceutical production,Hazardous Chemical Production(Manufactured under a valid license),Hazardous Chemicals Management(Operate with a valid license),generate electricity,power transmission,Power supply business,Import and export,Technology Import and Export,Import and export agency,Drug Wholesale,Drug import and export,Pharmaceutical commissioned production,Drug retail,Water production and supply.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Heat production and supply,Feed Additive Sales,Food Additive Sales,Chemical product production(No licensed chemical products),Chemical product sales(No licensed chemical products),Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals),Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),Specialty Chemicals Sales(Free of Hazardous Chemicals),Manufacturing of daily chemical products,Sales of daily chemical products,Sales of new catalytic materials and additives,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,housing lease,Cooling service,business management,Sewage treatment and recycling,Unit logistics management service,Non-residential real estate leases,Loading and unloading,Air Pollution Treatment.(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)